Real-world study checks if jivi keeps joints healthy in hemophilia a patients
NCT ID NCT05643560
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 31 times
Summary
This study looks at adults with hemophilia A who choose to take Jivi, a longer-lasting clotting factor, to prevent bleeding. Researchers will use ultrasound to check joint health after 24 months of treatment. The goal is to see if Jivi helps maintain or improve joint status in everyday life.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Many Locations
Multiple Locations, Italy
Conditions
Explore the condition pages connected to this study.